title: Cost Effectiveness of Colorectal Cancer Screening Strategies.
abstract: BACKGROUND
  Several screening tests are available to detect colorectal cancer (CRC) and reduce the incidence and mortality of CRC. The purpose of this review was to determine how current CRC screening strategies for CRC compare with no screening and whether agreement exists with regard to the cost effectiveness of different strategies.
  
  
  METHODS
  Databases were searched for cost-effectiveness analyses focused on CRC screening strategies in the United States and published between May 2007 and February 2014. We analyzed the uses of fecal occult blood, fecal immunochemistry, and stool DNA tests, as well as sigmoidoscopy, colonoscopy, and virtual colonoscopy. A paired comparison of each screening strategy with no screening across each of the studies reviewed was conducted. A series of paired comparisons of the results reported in each of the studies is also included.
  
  
  RESULTS
  When compared with no screening, all CRC screening strategies evaluated in this review were cost effective. There was disagreement as to which screening strategy was the most cost effective. However, sigmoidoscopy combined with fecal blood testing always dominated either strategy alone. Studies comparing colonoscopy with fecal blood testing, sigmoidoscopy, or both had mixed results.
  
  
  CONCLUSIONS
  Compared with no screening, all CRC screening strategies are more cost effective. Study results disagree as to which screening strategy should be the preferred method.
authors.affiliation: Department of Health Care Organization and Policy, Birmingham, AL 35294-0022, USA. mkilgore@uab.edu.
authors.forename: Shaan S
authors.initials: SS
authors.lastname: Patel
authors.forename: Meredith L
authors.initials: ML
authors.lastname: Kilgore
mesh_terms: D023881:Colonography, Computed Tomographic / Q000191:economics; D003113:Colonoscopy / Q000191:economics*; D015179:Colorectal Neoplasms / Q000175:diagnosis*; D003362:Cost-Benefit Analysis; D055088:Early Detection of Cancer / Q000191:economics* / Q000379:methods*; D006801:Humans; D007150:Immunohistochemistry; D009780:Occult Blood; D012812:Sigmoidoscopy / Q000191:economics; D014481:United States